Tailored P2Y 12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score stu...
Tailored P2Y 12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study
About this item
Full title
Tailored P2Y 12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study
Author / Creator
Publisher
Germany
Journal title
European journal of clinical pharmacology, 2019-09, Vol.75 (9), p.1201
Language
English
Formats
Publication information
Publisher
Germany
Subjects
More information
Scope and Contents
Contents
The POPular Risk Score was developed for the selective intensification of P2Y
inhibitor treatment with prasugrel instead of clopidogrel in patients undergoing non-urgent percutaneous coronary intervention (PCI) with stent implantation. This score is based on platelet reactivity (VerifyNow P2Y
assay), CYP2C19 genotyping, and clinical risk fact...
Alternative Titles
Full title
Tailored P2Y 12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_31197411
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_31197411
Other Identifiers
E-ISSN
1432-1041
DOI
10.1007/s00228-019-02696-z
